Free Trial
NASDAQ:TLIS

Talis Biomedical 5/8/2024 Earnings Report

Talis Biomedical logo
$1.50 0.00 (0.00%)
As of 08/12/2025 12:18 PM Eastern

Talis Biomedical EPS Results

Actual EPS
-$7.15
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$0.07 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Talis Biomedical's next earnings date is estimated for Monday, August 18, 2025, based on past reporting schedules.

Conference Call Resources

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
Tesla is in trouble
This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardware is so essential that the data center industry uses enough of it to stretch around the world 8 times – in a single building! So, if you own Nvidia stock now, you might be well-served to sell those shares and check out this under-the-radar play instead. Or if you missed the boat on Nvidia, this is a rare second chance to target tremendous profit potential as AI data centers spring up in every corner of the world.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat